PD-1/PD-L1 signaling pathway is considered to be a key immune barrier pathway to inhibit the activation of CD8+ T, and the activation of this pathway can inhibit the recognition and killing function of CD8+ T on cancer cells, resulting in cancer cells escaping the surveillance and killing of the immune system [8]. The gene discussed is CD8A; the disease is cancer.